Lance Armstrong: 'If Chris Froome races the Tour, it'll be a nightmare for him'
Armstrong criticises media coverage of salbutamol case
Chris Froome will face a "nightmare" situation if he rides the Tour de France in 2018 after his and Team Sky's problems over the last year, according to Lance Armstrong.
Armstrong won the Tour de France seven times, titles that were stripped when authorities showed he doped for most of his career. In his podcast series, he spoke about Froome's recent high-level reading case involving asthma drug salbutamol.
"He should be allowed due process to explain what happened here and he could be completely exonerated, but he is tarnished forever. Damage is done," said Armstrong.
"This investigation could go on for months. Come next July, riding around France... It is already unpleasant for him. This is going to it's going to be complete mayhem. It's a nightmare."
>>> Everything you need to know about Chris Froome's salbutamol case
Fans at past editions of the Tour de France have already attacked Team Sky riders, with one even throwing urine over Froome at the 2015 edition of the race.
In the last year, Sky have faced a number of controversies, such as the contents of a mysterious Jiffy bad delivered to the team at the Critérium du Dauphiné in 2011, with UK Anti-Doping unable to ascertain what was in the package.
Get The Leadout Newsletter
The latest race content, interviews, features, reviews and expert buying guides, direct to your inbox!
Froome, who denies any wrongdoing, delivered an adverse analytical finding after his urine was found to contain 2000 nanograms of salbutamol per millilitre (ng/ml) - twice the permitted limit - after the 18th stage of the Vuelta a España, which he eventually won.
Watch: Tour de France 2018 route guide
He and the team were informed after the Vuelta on September 20. Since, they have been trying work with the UCI anti-doping programme to explain the high reading and prove that it was not due to Froome exceeding the maximum permitted dosage for the asthma medication. News of the adverse finding leaked out via Le Monde and Guardian articles last Wednesday.
"I don't know why this has been leaked to the media," Armstrong added. "Whoever leaked this had to remain anonymous and this happens a lot in our sport. It's frustrating."
Regardless of why Froome's urine had so much salbutamol or why the case became public, Armstrong echoed Romain Bardet as he said that the image of Froome, Team Sky and cycling will suffer.
>>> Chris Froome should be 'voluntarily suspended' by Team Sky, says anti-doping group
"Cycling is the sporting world's doormat and by the way, I have to take a lot of blame for that," Armstrong explained.
"I am trying to accept some responsibility here because I have tainted the whole equation, obviously, but I read a story in the New York Times that was so harsh on Froome and the sport. You don't get an accurate depiction of this situation by reading that.
"This is so easy for the press to go after cycling and some of the bull**** I have read on this story has been so harsh."
Froome told BBC Sport last week that that his legacy would not be permanently stained from the high salbutamol test.
"I can understand a lot of people's reactions, especially given the history of the sport. This is not a positive test."
Thank you for reading 20 articles this month* Join now for unlimited access
Enjoy your first month for just £1 / $1 / €1
*Read 5 free articles per month without a subscription
Join now for unlimited access
Try first month for just £1 / $1 / €1
Gregor Brown is an experienced cycling journalist, based in Florence, Italy. He has covered races all over the world for over a decade - following the Giro, Tour de France, and every major race since 2006. His love of cycling began with freestyle and BMX, before the 1998 Tour de France led him to a deep appreciation of the road racing season.
-
‘There's no point to race for 50th place’: Peter Sagan explains why he’s a cycling esports ambassador but won’t compete
As a MyWhoosh ambassador, Sagan admires the sport’s evolution, but does he have the watts to compete with today’s virtual cycling stars?
By Christopher Schwenker Published
-
Rapha's loss, your gain: prices slashed sitewide amid profitability concerns
The British clothing brand unveils an almost unheard-of 25% discount across its entire product range
By Hannah Bussey Published
-
Chris Froome misses out on Tour de France selection
39-year-old absent from Israel-Premier Tech's eight-rider roster
By Tom Davidson Published
-
A complete history of Ineos Grenadiers kits, from Adidas to Gobik, via Rapha
The British team switch to Gobik in 2024 after two years with Bioracer
By Tom Thewlis Published
-
Chris Froome's boss rubbishes claims bike fit is behind lack of results
'He can talk about his bike position until the cows come home - that's still not going to earn him a position on a Grand Tour team' says Israel-Premier Tech team owner Sylvan Adams
By Tom Thewlis Published
-
Chris Froome, rim brake evangelist, 'warms to' disc brakes
The Israel-Premier Tech rider, also an investor at Factor Bikes, says that he has "way less problems" with discs these days
By Adam Becket Published
-
Is Chris Froome - in 2023 - a professional cyclist, or an influencer?
The seven-time Grand Tour winner hasn't raced since July, but has taken to being interesting on social media
By Adam Becket Published
-
Chris Froome 'absolutely not' worth multi-million euro salary says his team boss
The four-time Tour de France winner was not selected for this year's Tour de France for performance reasons, Israel-Premier Tech boss Sylvan Adams says
By Chris Marshall-Bell Published
-
Chris Froome not selected for Tour de France 2023
38-year-old misses out on 'ultimate goal' as Israel-Premier Tech confirm eight-man squad
By Tom Davidson Published
-
Back to Africa: Chris Froome on going back to his roots, his future and cycling's new generation
He’s come full circle, but is there time for another loop? We talk to the four-time Tour champ about his and African cycling’s future
By Adam Becket Published